One year in review 2020: economic and organisational aspects in rare and complex connective tissue diseases.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 15 09 2020
accepted: 27 10 2020
pubmed: 27 11 2020
medline: 15 12 2020
entrez: 26 11 2020
Statut: ppublish

Résumé

Rare and complex connective tissue diseases (rCTDs) encompass a considerable number of diseases and syndromes and their variability highly impacts on the clinical management, resulting in variable economic and organisational burden that might represent a challenge for healthcare systems. This paper is aimed at providing an overview of the most recent evidence regarding the economic and organisational impact of rCTDs. In particular, this work discusses the most relevant data on specific aspects related to health economics in rCTDs published in 2019.

Identifiants

pubmed: 33242303
pii: 16445

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1037-1045

Auteurs

Sara Cannizzo (S)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Ilaria Palla (I)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Salvatore Pirri (S)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Isotta Triulzi (I)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Claudio Carta (C)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Domenica Taruscio (D)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Giuseppe Turchetti (G)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy. giuseppe.turchetti@santannapisa.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH